NASDAQ · AAPG
Ascentage Pharma Group International American Depository Shares financials
$15.35+3.09%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $82.1M |
| Gross profit | $75.1M |
| Gross margin | 91.5% |
| Operating income | -$183.8M |
| Net income | -$177.6M |
| Net margin | −216.5% |
| Diluted EPS | $-0.50 |
| EBITDA | -$172.9M |
| Operating cash flow | -$167.8M |
| Free cash flow | -$171.8M |
| Diluted shares | 356.1M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $353.1M |
| Short-term investments | $0.00 |
| Total debt | $283.0M |
| Total assets | $566.5M |
| Total liabilities | $375.8M |
| Shareholders' equity | $190.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology